TrialBMC cancer2015

Phase II study of axitinib with doublet chemotherapy in patients with advanced squamous non-small-cell lung cancer.

Igor M Bondarenko et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.